// App-Quantinova.ai

1105-110 : BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF >40,000 PATIENTS

Researchers

Presenter

  • Ashish Adrian Correa

Principal Investigators

  • Abel Casso Dominguez

  • Jacqueline Tamis-Holland

  • Mount Sinai

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • Acetyl-CoA carboxylase

  • Ephrin type-B receptor 6

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved